OQS
CDTX

Occudo Quantitative Strategies’s Cidara Therapeutics CDTX Stock Holding History

Occudo Quantitative Strategies’s Portfolio CDTX Stock Details CDTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-726
Closed -$12K – 1155
2022
Q1 		$12K Sell
726
-108
-13% -$1.83K ﹤0.01% 1105
2021
Q4 		$21K Sell
834
-351
-30% -$10.9K ﹤0.01% 1037
2021
Q3 		$53K Sell
1,185
-411
-26% -$15.6K 0.01% 967
2021
Q2 		$64K Buy
1,596
+289
+22% +$12.2K 0.01% 833
2021
Q1 		$70K Buy
1,307
+410
+46% +$20.2K 0.02% 709
2020
Q4 		$36K Buy
+897
New +$44.6K 0.01% 623

Other funds holding CDTX

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $195M AUM 51.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Occudo Quantitative Strategies's CDTX Position: Q2 2022 in Review

Occudo Quantitative Strategies sold out of Cidara Therapeutics (CDTX) in Q2 2022, closing a stake of 726 shares — an estimated $12K sold.

Occudo Quantitative Strategies first reported a position in CDTX in Q4 2020 and held it in 6 quarters. The position peaked at $70K in Q1 2021. 46 funds tracked by Wall St. Rank hold CDTX as of Q2 2022.

  • Occudo Quantitative Strategies reported no remaining Cidara Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 726 Cidara Therapeutics shares in Q2 2022, an estimated $12K.
  • Occudo Quantitative Strategies first reported a position in Cidara Therapeutics in Q4 2020 and held it in 6 quarters.
  • Occudo Quantitative Strategies's Cidara Therapeutics position peaked at $70K in Q1 2021.
  • 46 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q2 2022.

Based on Occudo Quantitative Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.